US EditionPublished • loading... • Updated
NJ Bio Bridges the Translation Research Gap with the Asset Purchase and Integration of L2P® Services
Summary by Financial Post
2 Articles
2 Articles
PRINCETON, N.J.--(BUSINESS WIRE)--Nov 6, 2025-
NJ Bio Bridges the Translation Research Gap with the Asset Purchase and Integration of L2P® Services
PRINCETON, N.J. -- NJ Bio, Inc., a premier contract research and clinical manufacturing service provider in Princeton, New Jersey has announced the asset purchase and full integration of the research services of L2P Research Labs® (“Lab to Pharmacy”), further expanding its service portfolio, and bridging the translational research gap.
·Canada
Read Full ArticleCoverage Details
Total News Sources2
Leaning Left0Leaning Right1Center1Last UpdatedBias Distribution50% Center, 50% Right
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
50% Right
C 50%
R 50%
Factuality
To view factuality data please Upgrade to Premium
